|
JP4812942B2
(ja)
*
|
1999-02-26 |
2011-11-09 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
ＣＧモチーフを含むオリゴヌクレオチドを用いるＮｅｉｓｓｅｒｉａ抗原殺菌活性の増強
|
|
DK1328543T3
(da)
*
|
2000-10-27 |
2009-11-23 |
Novartis Vaccines & Diagnostic |
Nukleinsyrer og proteiner fra streptococcus-gruppe A & B
|
|
US7082569B2
(en)
|
2001-01-17 |
2006-07-25 |
Outlooksoft Corporation |
Systems and methods providing dynamic spreadsheet functionality
|
|
AU2006214064B2
(en)
|
2005-02-18 |
2012-04-26 |
J. Craig Venter Institute, Inc. |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
|
US8398983B2
(en)
|
2005-06-27 |
2013-03-19 |
Glaxosmithkline Biologicals, S.A. |
Immunogenic composition
|
|
WO2008020330A2
(en)
|
2006-08-16 |
2008-02-21 |
Novartis Ag |
Immunogens from uropathogenic escherichia coli
|
|
ITMI20081249A1
(it)
*
|
2008-07-09 |
2010-01-09 |
Novartis Vaccines & Diagnostic |
Immunogeni di escherichia coli con solubilità migliorata.
|
|
JP5332237B2
(ja)
*
|
2008-03-06 |
2013-11-06 |
味の素株式会社 |
Ｌ−システイン生産菌及びｌ−システインの製造法
|
|
US8647642B2
(en)
|
2008-09-18 |
2014-02-11 |
Aviex Technologies, Llc |
Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
|
|
NZ591768A
(en)
|
2008-09-18 |
2012-11-30 |
Novartis Ag |
Vaccine adjuvant combinations
|
|
WO2010124085A2
(en)
*
|
2009-04-23 |
2010-10-28 |
Cornell University |
Compositions and methods for preventing and treating uterine disease
|
|
WO2010129578A1
(en)
*
|
2009-05-06 |
2010-11-11 |
Cornell Research Foundation, Inc. |
E. coli lpfa antigen for prevention and treatment of infectious diseases
|
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
|
WO2011008400A2
(en)
|
2009-06-16 |
2011-01-20 |
Novartis Ag |
High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
|
|
WO2011004263A2
(en)
|
2009-07-07 |
2011-01-13 |
Novartis Ag |
Conserved escherichia coli immunogens
|
|
PL2464658T3
(pl)
|
2009-07-16 |
2015-03-31 |
Novartis Ag |
Immunogeny z Escherichia coli o zniesionej toksyczności
|
|
EP2277989A1
(en)
|
2009-07-24 |
2011-01-26 |
Technische Universiteit Delft |
Fermentative glycerol-free ethanol production
|
|
CN102740882A
(zh)
|
2009-08-27 |
2012-10-17 |
诺华有限公司 |
含有铝、寡核苷酸和聚阳离子的佐剂
|
|
ES2443952T3
(es)
|
2009-09-02 |
2014-02-21 |
Novartis Ag |
Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
|
|
ES2387719T3
(es)
*
|
2009-09-10 |
2012-09-28 |
Freie Universität Berlin |
Identificación y caracterización de una nueva adhesina fimbrial de E. coli patógena aviar (APEC)
|
|
DK2482836T3
(en)
*
|
2009-10-02 |
2016-06-06 |
Univ Oslo Hf |
Antibacterial polypeptides and the use thereof
|
|
US8741591B2
(en)
|
2009-10-09 |
2014-06-03 |
The Research Foundation For The State University Of New York |
pH-insensitive glucose indicator protein
|
|
EP2509961B1
(en)
|
2009-12-11 |
2016-03-09 |
Autifony Therapeutics Limited |
Imidazolidinedione derivatives
|
|
JP5781542B2
(ja)
*
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原
|
|
US9770463B2
(en)
|
2010-07-06 |
2017-09-26 |
Glaxosmithkline Biologicals Sa |
Delivery of RNA to different cell types
|
|
RS63817B1
(sr)
|
2010-07-06 |
2023-01-31 |
Glaxosmithkline Biologicals Sa |
Čestice za isporuku slične virionu za molekule samoreplicirajuće rnk
|
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
|
PL2591114T3
(pl)
|
2010-07-06 |
2017-08-31 |
Glaxosmithkline Biologicals Sa |
Immunizacja dużych ssaków małymi dawkami rna
|
|
HUE047796T2
(hu)
|
2010-07-06 |
2020-05-28 |
Glaxosmithkline Biologicals Sa |
RNS bevitele több immunútvonal bekapcsolására
|
|
HUE026646T2
(en)
|
2010-07-06 |
2016-07-28 |
Glaxosmithkline Biologicals Sa |
Preferred liposomes containing lipids of PKA value for delivery of RNA
|
|
PT3970742T
(pt)
|
2010-08-31 |
2022-06-27 |
Glaxosmithkline Biologicals Sa |
Lipossomas peguilados para entrega de arn codificador de imunogénio
|
|
ES2727583T3
(es)
|
2010-08-31 |
2019-10-17 |
Glaxosmithkline Biologicals Sa |
Lípidos adecuados para la administración liposómica de ARN que codifica proteínas
|
|
ES2458355T3
(es)
|
2010-09-01 |
2014-05-05 |
Novartis Ag |
Adsorción de inmunopotenciadores sobre sales metálicas insolubles
|
|
BR112013005626B1
(pt)
*
|
2010-09-10 |
2022-07-26 |
Glaxosmithkline Biologicals Sa |
Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição
|
|
JP2013544504A
(ja)
|
2010-10-11 |
2013-12-19 |
ノバルティス アーゲー |
抗原送達プラットフォーム
|
|
US9618508B2
(en)
|
2010-12-14 |
2017-04-11 |
Glaxosmithkline Biologicals Sa |
Flow cytometry analysis of materials adsorbed to metal salts
|
|
US10286056B2
(en)
|
2011-01-27 |
2019-05-14 |
Glaxosmithkline Biologicals S.A. |
Adjuvant nanoemulsions with crystallisation inhibitors
|
|
US10512661B2
(en)
|
2011-02-04 |
2019-12-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
|
US10940169B2
(en)
|
2015-11-30 |
2021-03-09 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing cancer in an individual human being
|
|
US12257272B2
(en)
|
2015-12-24 |
2025-03-25 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing depression in an individual
|
|
US10010568B2
(en)
|
2011-02-04 |
2018-07-03 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a spirochetes infection in a human being
|
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
US10835560B2
(en)
|
2013-12-20 |
2020-11-17 |
Joseph E. Kovarik |
Reducing the likelihood of skin cancer in an individual human being
|
|
US10583033B2
(en)
|
2011-02-04 |
2020-03-10 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US10548761B2
(en)
|
2011-02-04 |
2020-02-04 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
|
US11273187B2
(en)
|
2015-11-30 |
2022-03-15 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing depression in an individual
|
|
US12279989B2
(en)
|
2011-02-04 |
2025-04-22 |
Seed Health, Inc. |
Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
|
|
US10842834B2
(en)
|
2016-01-06 |
2020-11-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US9987224B2
(en)
|
2011-02-04 |
2018-06-05 |
Joseph E. Kovarik |
Method and system for preventing migraine headaches, cluster headaches and dizziness
|
|
US10111913B2
(en)
|
2011-02-04 |
2018-10-30 |
Joseph E. Kovarik |
Method of reducing the likelihood of skin cancer in an individual human being
|
|
US11191665B2
(en)
|
2011-02-04 |
2021-12-07 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
|
US10687975B2
(en)
|
2011-02-04 |
2020-06-23 |
Joseph E. Kovarik |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US12533312B2
(en)
|
2011-02-04 |
2026-01-27 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
|
US11523934B2
(en)
|
2011-02-04 |
2022-12-13 |
Seed Health, Inc. |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US10245288B2
(en)
|
2011-02-04 |
2019-04-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US10085938B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for preventing sore throat in humans
|
|
US11357722B2
(en)
|
2011-02-04 |
2022-06-14 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
|
US10086018B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
|
US11419903B2
(en)
|
2015-11-30 |
2022-08-23 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
WO2012117377A1
(en)
|
2011-03-02 |
2012-09-07 |
Novartis Ag |
Combination vaccines with lower doses of antigen and/or adjuvant
|
|
WO2012129483A1
(en)
|
2011-03-24 |
2012-09-27 |
Novartis Ag |
Adjuvant nanoemulsions with phospholipids
|
|
US20140141070A1
(en)
|
2011-07-06 |
2014-05-22 |
Andrew Geall |
Liposomes having useful n:p ratio for delivery of rna molecules
|
|
WO2013006838A1
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Immunogenic combination compositions and uses thereof
|
|
EP3508220A1
(en)
|
2011-08-31 |
2019-07-10 |
GlaxoSmithKline Biologicals S.A. |
Pegylated liposomes for delivery of immunogen-encoding rna
|
|
WO2013038385A2
(en)
|
2011-09-14 |
2013-03-21 |
Novartis Ag |
Escherichia coli vaccine combination
|
|
KR101359844B1
(ko)
*
|
2012-01-06 |
2014-02-25 |
씨제이제일제당 (주) |
퀴놀린산을 생산하는 재조합 미생물 및 이를 이용한 퀴놀린산의 생산 방법
|
|
JP5961635B2
(ja)
*
|
2012-01-18 |
2016-08-02 |
三井化学株式会社 |
１、５−ペンタメチレンジアミンの製造方法
|
|
MX346678B
(es)
|
2012-03-07 |
2017-03-29 |
Novartis Ag |
Sales de arginina utiles inmunologicamente.
|
|
JP2015510872A
(ja)
|
2012-03-07 |
2015-04-13 |
ノバルティス アーゲー |
Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤
|
|
MX372965B
(es)
|
2012-03-08 |
2020-04-01 |
Glaxosmithkline Biologicals Sa |
Formulaciones adyuvadas de vacunas de difteria, tetanos y tos ferina (dtp) de refuerzo.
|
|
CN104812773B
(zh)
*
|
2012-07-20 |
2018-04-06 |
庆熙大学校产学协力团 |
表位标记用抗体、杂交瘤细胞株以及其用途
|
|
US9764027B2
(en)
|
2012-09-18 |
2017-09-19 |
Glaxosmithkline Biologicals Sa |
Outer membrane vesicles
|
|
DK2909334T3
(da)
*
|
2012-10-17 |
2020-09-28 |
Enterome |
Gensignaturer af inflammatoriske lidelser, som er relateret til leveren og Crohns sygdom
|
|
US10288610B2
(en)
*
|
2012-11-13 |
2019-05-14 |
The General Hospital Corporation |
Vitro assays for detecting Salmonella enterica serotype typhi
|
|
WO2014102694A1
(en)
|
2012-12-24 |
2014-07-03 |
Novartis Ag |
Novel mucinase for use in therapy or prophylaxis
|
|
EP3608308B1
(en)
|
2013-03-08 |
2021-07-21 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
|
WO2014204578A1
(en)
|
2013-06-21 |
2014-12-24 |
The General Hospital Corporation |
Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
|
|
AU2014227653B2
(en)
|
2013-03-15 |
2017-04-20 |
The General Hospital Corporation |
Using RNA-guided foki nucleases (RFNs) to increase specificity for RNA-guided genome editing
|
|
KR101525663B1
(ko)
*
|
2013-05-10 |
2015-06-04 |
씨제이제일제당 (주) |
신규 ｏ-포스포세린 배출 단백질 및 이를 이용한 ｏ-포스포세린의 생산방법
|
|
US11274144B2
(en)
|
2013-06-13 |
2022-03-15 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the removal of biofilms
|
|
EP3027205A4
(en)
*
|
2013-07-28 |
2017-07-19 |
Qantu Therapeutics, Inc. |
Vaccine formulations that induce a th2 immune response
|
|
KR20150018227A
(ko)
*
|
2013-08-09 |
2015-02-23 |
삼성전자주식회사 |
외인성 푸마라아제 유전자를 포함하는 코리네박테리움 및 이를 이용한 c4 디카르복실산의 생산 방법
|
|
US11248040B2
(en)
|
2013-09-26 |
2022-02-15 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
AU2014346559B2
(en)
|
2013-11-07 |
2020-07-09 |
Editas Medicine,Inc. |
CRISPR-related methods and compositions with governing gRNAs
|
|
EP4019506A1
(en)
|
2013-12-19 |
2022-06-29 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
ES2895651T3
(es)
|
2013-12-19 |
2022-02-22 |
Novartis Ag |
Lípidos y composiciones lipídicas para la administración de agentes activos
|
|
US12329783B2
(en)
|
2013-12-20 |
2025-06-17 |
Seed Health, Inc. |
Method and system to improve the health of a person's skin microbiome
|
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
|
US11642382B2
(en)
|
2013-12-20 |
2023-05-09 |
Seed Health, Inc. |
Method for treating an individual suffering from bladder cancer
|
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
|
US11213552B2
(en)
|
2015-11-30 |
2022-01-04 |
Joseph E. Kovarik |
Method for treating an individual suffering from a chronic infectious disease and cancer
|
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
|
US11529379B2
(en)
|
2013-12-20 |
2022-12-20 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
|
|
US12246043B2
(en)
|
2013-12-20 |
2025-03-11 |
Seed Health, Inc. |
Topical application to treat acne vulgaris
|
|
US11672835B2
(en)
|
2013-12-20 |
2023-06-13 |
Seed Health, Inc. |
Method for treating individuals having cancer and who are receiving cancer immunotherapy
|
|
US12318377B2
(en)
|
2013-12-20 |
2025-06-03 |
Seed Health, Inc. |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
|
US11026982B2
(en)
|
2015-11-30 |
2021-06-08 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
|
|
US10624934B2
(en)
|
2014-03-06 |
2020-04-21 |
Research Institute At Nationwide Children's Hospital |
Prebiotic formulations
|
|
AU2015227075A1
(en)
*
|
2014-03-06 |
2016-09-22 |
Ohio State Innovation Foundation |
Probiotic formulations and methods for use
|
|
CL2014001126A1
(es)
*
|
2014-04-29 |
2014-08-29 |
Univ Chile |
Composición farmacéutica útil como vacuna contra bacterias escherichia coli productoras de shigatoxinas (stec), que comprende al menos un antígeno o una proteína de membrana externa inmunogénica o proteína inmunogénica asociada y conservada en cepas stec.
|
|
EP3169309B1
(en)
|
2014-07-16 |
2023-05-10 |
Novartis AG |
Method of encapsulating a nucleic acid in a lipid nanoparticle host
|
|
US10125092B2
(en)
|
2014-09-05 |
2018-11-13 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
EP3061826A1
(en)
|
2015-02-27 |
2016-08-31 |
Novartis AG |
Flavivirus replicons
|
|
CN107771214B
(zh)
*
|
2015-04-07 |
2022-01-18 |
代谢探索者公司 |
用于具有增加的2,4-二羟基丁酸外排物的优化的2,4-二羟基丁酸产生的修饰的微生物
|
|
US20160317615A1
(en)
*
|
2015-05-01 |
2016-11-03 |
Jose Javier Lopez GONZALEZ |
T cell modulator
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11209972B2
(en)
|
2015-09-02 |
2021-12-28 |
D&M Holdings, Inc. |
Combined tablet screen drag-and-drop interface
|
|
WO2016210384A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
AU2016303688B2
(en)
|
2015-07-31 |
2023-06-15 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
US9926546B2
(en)
|
2015-08-28 |
2018-03-27 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
|
US11702636B2
(en)
|
2015-11-16 |
2023-07-18 |
National University Corporation Kumamoto University |
Composition inducing cell reprogramming and production method for multifunction cells using said composition
|
|
US10568916B2
(en)
|
2015-11-30 |
2020-02-25 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
|
US12239706B2
(en)
|
2015-11-30 |
2025-03-04 |
Seed Health, Inc. |
Method and system for protecting monarch butterflies from pesticides
|
|
US10086024B2
(en)
|
2015-11-30 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
|
US10933128B2
(en)
|
2015-11-30 |
2021-03-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees from pesticides
|
|
US11529412B2
(en)
|
2015-11-30 |
2022-12-20 |
Seed Health, Inc. |
Method and system for protecting honey bees from pesticides
|
|
US10675347B2
(en)
|
2015-11-30 |
2020-06-09 |
Joseph E. Kovarik |
Method and system for protecting honey bees from fipronil pesticides
|
|
WO2017127731A1
(en)
*
|
2016-01-21 |
2017-07-27 |
T2 Biosystems, Inc. |
Nmr methods and systems for the rapid detection of bacteria
|
|
US11155578B2
(en)
|
2016-02-17 |
2021-10-26 |
Pepticom Ltd. |
Peptide agonists and antagonists of TLR4 activation
|
|
US11248270B2
(en)
*
|
2016-03-14 |
2022-02-15 |
The Translational Genomics Research Institute |
Methods and kits to identify Klebsiella strains
|
|
CN108884483A
(zh)
*
|
2016-03-16 |
2018-11-23 |
帝斯曼知识产权资产管理有限公司 |
烟酸核糖苷的微生物生产
|
|
KR102253900B1
(ko)
*
|
2016-04-27 |
2021-05-18 |
바이오셀즈(베이징) 바이오테크 코., 엘티디. |
흥분성 신경독성 관련 손상 치료용 펩타이드
|
|
GB201617548D0
(en)
*
|
2016-10-17 |
2016-11-30 |
Linnane Pharma Ab |
Novel biological factor
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
ES3024474T3
(en)
|
2016-12-30 |
2025-06-04 |
Vaxcyte Inc |
Polypeptide-antigen conjugates with non-natural amino acids
|
|
JP7514621B2
(ja)
|
2017-01-04 |
2024-07-11 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
Ｄｎａｂｉｉワクチンおよび強化された活性を有する抗体
|
|
AU2018206560B9
(en)
|
2017-01-04 |
2025-04-03 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
|
WO2018200894A1
(en)
|
2017-04-28 |
2018-11-01 |
Intrexon Corporation |
Methods and microorganisms for the fermentation of methane to multi-carbon compounds
|
|
KR101943081B1
(ko)
*
|
2017-08-31 |
2019-01-29 |
(주)케어젠 |
주름 개선 활성을 나타내는 펩타이드 및 이의 용도
|
|
WO2019147743A1
(en)
|
2018-01-26 |
2019-08-01 |
Massachusetts Institute Of Technology |
Structure-guided chemical modification of guide rna and its applications
|
|
EP3821026A4
(en)
|
2018-07-09 |
2022-06-01 |
Codexis, Inc. |
MANIPULATED ENZYME VARIANTS OF PHOSPHOPENTOMUTASE
|
|
US12150967B2
(en)
|
2018-08-18 |
2024-11-26 |
Seed Health, Inc. |
Methods and compositions for honey bee health
|
|
JP7541513B2
(ja)
*
|
2018-10-05 |
2024-08-28 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
細菌バイオフィルムの酵素的破壊のための組成物および方法
|
|
SG11202103001PA
(en)
|
2018-10-05 |
2021-04-29 |
Res Inst Nationwide Childrens Hospital |
Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application
|
|
US12569524B2
(en)
|
2018-10-22 |
2026-03-10 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for preventing and treating antibiotic induced pathologies using probiotics in the biofilm state
|
|
KR101991207B1
(ko)
|
2018-11-29 |
2019-06-19 |
씨제이제일제당 (주) |
cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법
|
|
KR101996767B1
(ko)
*
|
2018-11-29 |
2019-07-04 |
씨제이제일제당 (주) |
cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법
|
|
KR101991206B1
(ko)
*
|
2018-11-29 |
2019-06-19 |
씨제이제일제당 (주) |
cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법
|
|
WO2020117715A1
(en)
|
2018-12-03 |
2020-06-11 |
Board Of Regents, The University Of Texas System |
Oligo-benzamide analogs and their use in cancer treatment
|
|
WO2020123569A1
(en)
*
|
2018-12-10 |
2020-06-18 |
Flagship Pioneering Innovations Vi, Llc |
Achromosomal dynamic active systems
|
|
US20220211872A1
(en)
*
|
2019-05-15 |
2022-07-07 |
Universidad De Granada |
Gene therapy with the genes hokd and ldrb for cancer treatments
|
|
WO2020247536A1
(en)
|
2019-06-03 |
2020-12-10 |
Research Institute At Nationwide Children's Hospital |
Prebiotic formulations for prevention of sepsis and necroenterocolitis induced neurodevelopmental deficiencies
|
|
US10920189B2
(en)
*
|
2019-06-21 |
2021-02-16 |
Inscripta, Inc. |
Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli
|
|
CN110441284B
(zh)
*
|
2019-07-23 |
2022-02-15 |
海南大学 |
一种可用于痕量检测的表面增强拉曼散射芯片的制备方法及所得产品和应用
|
|
KR102183209B1
(ko)
*
|
2019-09-09 |
2020-11-26 |
씨제이제일제당 주식회사 |
L-쓰레오닌 배출 단백질의 변이체 및 이를 이용한 l-쓰레오닌 생산 방법
|
|
WO2021085405A1
(ja)
*
|
2019-10-28 |
2021-05-06 |
味の素株式会社 |
ベンズアルデヒドの製造方法
|
|
KR20220119408A
(ko)
*
|
2019-12-20 |
2022-08-29 |
바스프 에스이 |
터펜의 독성 감소 및 미생물에서 생산 잠재성 증가
|
|
US20230105474A1
(en)
*
|
2020-02-25 |
2023-04-06 |
Synlogic Operating Company, Inc. |
Recombinant bacteria engineered to treat diseases associated with uric acid and methods of use thereof
|
|
CN111778224B
(zh)
*
|
2020-07-20 |
2021-06-01 |
成都薇合生物科技有限公司 |
尿酸酶或其同源酶及其应用
|
|
MX2023002421A
(es)
|
2020-08-28 |
2023-05-18 |
Codexis Inc |
Variantes de amilasa modificadas geneticamente.
|
|
EP4225909A4
(en)
*
|
2020-10-07 |
2025-02-12 |
Codexis, Inc. |
Engineered phosphopentomutase variant enzymes
|
|
CN112391331B
(zh)
*
|
2020-11-12 |
2022-09-27 |
江南大学 |
一种过表达GatA基因的重组大肠杆菌及其应用
|
|
KR102792504B1
(ko)
*
|
2020-12-28 |
2025-04-09 |
대상 주식회사 |
히스티딘에 의한 피드백 억제가 감소된 atp-prt 변이체 및 이를 발현하는 히스티딘 생산 균주
|
|
CN114137209B
(zh)
*
|
2021-02-01 |
2024-03-01 |
中国水产科学研究院黄海水产研究所 |
一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用
|
|
US11452757B2
(en)
*
|
2021-02-25 |
2022-09-27 |
Intron Biotechnology, Inc. |
Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same
|
|
KR20230164108A
(ko)
|
2021-04-01 |
2023-12-01 |
얀센 파마슈티칼즈, 인코포레이티드 |
E. coli O18 생물접합체의 생산
|
|
KR102707457B1
(ko)
*
|
2021-06-11 |
2024-09-20 |
씨제이제일제당 주식회사 |
신규한 MdtH 변이체 및 이를 이용한 O-포스포세린, 시스테인 및 이의 유도체의 생산방법
|
|
WO2023021421A1
(en)
|
2021-08-16 |
2023-02-23 |
Glaxosmithkline Biologicals Sa |
Low-dose lyophilized rna vaccines and methods for preparing and using the same
|
|
WO2023021427A1
(en)
|
2021-08-16 |
2023-02-23 |
Glaxosmithkline Biologicals Sa |
Freeze-drying of lipid nanoparticles (lnps) encapsulating rna and formulations thereof
|
|
US20250137050A1
(en)
*
|
2021-08-18 |
2025-05-01 |
The Regents Of The University Of California |
Methods and compositions for determining risk of autism spectrum disorders
|
|
CN113897324B
(zh)
*
|
2021-10-13 |
2023-07-28 |
云南师范大学 |
一种用作抗锰剂的JcVIPP1重组大肠杆菌及其构建方法
|
|
CN114107413B
(zh)
*
|
2021-11-03 |
2023-10-20 |
江苏香地化学有限公司 |
一种酶催化胞嘧啶生产胞苷的方法及应用
|
|
US11548917B1
(en)
*
|
2021-11-24 |
2023-01-10 |
Intron Biotechnology, Inc. |
Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same
|
|
US12516086B2
(en)
|
2021-12-21 |
2026-01-06 |
Sri International |
Dual targeting for cell-specific delivery to the central nervous system
|
|
CN114522230A
(zh)
*
|
2022-01-11 |
2022-05-24 |
上海市伤骨科研究所 |
一种蓝光和对苯醌联合杀菌方法
|
|
WO2023139605A1
(en)
*
|
2022-01-20 |
2023-07-27 |
Techinvention Lifecare Pvt. Ltd. |
Lysin polypeptides and compositions thereof against urinary tract infection caused by drug-resistant gram- negative bacteria
|
|
CN115286701A
(zh)
*
|
2022-03-07 |
2022-11-04 |
江苏靶标生物医药研究所有限公司 |
一种调节哺乳动物的肠道粘膜稳态或炎症性肠病的靶点及其应用
|
|
WO2023245129A2
(en)
*
|
2022-06-15 |
2023-12-21 |
Quantum-Si Incorporated |
Directed protein evolution
|
|
WO2024073730A2
(en)
*
|
2022-09-29 |
2024-04-04 |
The University Of Chicago |
Methods and systems for rna sequencing and analysis
|
|
AU2023362022A1
(en)
|
2022-10-19 |
2025-05-01 |
Glyprovac Aps |
Glycosylated yghj polypeptides from uropathogenic e. coli
|
|
CN118086235A
(zh)
*
|
2022-11-28 |
2024-05-28 |
宁波酶赛生物工程有限公司 |
一种合成d-泛解酸的酶催化剂和方法
|
|
KR102921214B1
(ko)
*
|
2023-01-31 |
2026-02-03 |
대상 주식회사 |
망가니즈 익스포터 신규 변이체 및 이를 이용한 l-히스티딘 생산 방법
|
|
GB202303019D0
(en)
|
2023-03-01 |
2023-04-12 |
Glaxosmithkline Biologicals Sa |
Method of lyophilisation
|
|
WO2025017339A1
(en)
*
|
2023-07-14 |
2025-01-23 |
Iowa State University Research Foundation, Inc. |
Escherichia coli nhaa membrane protein drug target and immunogenic compositions therefrom
|
|
CN116949027B
(zh)
*
|
2023-07-19 |
2024-12-24 |
浙江中医药大学 |
一种尿路致病性大肠埃希菌重组蛋白组合物ls、其构建、表达、纯化方法及其应用
|
|
GB202311382D0
(en)
|
2023-07-25 |
2023-09-06 |
Glaxosmithkline Biologicals Sa |
Lyophilised compostion
|
|
WO2025219177A1
(en)
|
2024-04-18 |
2025-10-23 |
Glyprovac Aps |
Optimized plasmids for expression of yghj polypeptides
|
|
CN118388664B
(zh)
*
|
2024-05-21 |
2024-12-03 |
广东省农业科学院动物卫生研究所 |
副猪嗜血杆菌融合抗原及其应用
|
|
WO2026033498A1
(en)
|
2024-08-09 |
2026-02-12 |
Genvax Technologies, Inc. |
Methods of self-amplifying rna-lipid nanoparticle manufacture and compositions derived therefrom
|
|
CN119061031A
(zh)
*
|
2024-10-08 |
2024-12-03 |
安徽农业大学 |
一种水稻抗除草剂突变基因及其应用
|